Secondary Outcome Measures,,,
Determination of Signal transducer and activator of transcription 3 (STAT3) levels, Serum STAT3 levels will be measured by means of the human enzyme-linked immunosorbent assay (ELISA) technique according to the manufacturers protocol, Baseline,12 weeks
Determination of Toll-like receptor4 (TLR-4) levels, Serum TLR4 levels will be measured by means of the human enzyme-linked immunosorbent assay (ELISA) technique according to the manufacturers protocol., Baseline,12 weeks
Determination of interleukin-1β (IL-1β) levels, Serum IL-1β levels will be measured by means of the human enzyme-linked immunosorbent assay (ELISA) technique according to the manufacturers protocol., Baseline, 12 weeks
Determination of Malondialdehyde (MDA) levels, Serum MDA levels will be measured by means of the human enzyme-linked immunosorbent assay (ELISA) technique according to the manufacturers protocol, Baseline, 12 weeks
